March 03, 2020
Rose
President Donald Trump met with pharma executives in a meeting that had once been billed as a scolding over high prices. But now that the industry is needed to help develop a vaccine for the emerging pandemic, Trump has taken a more congenial tone with the executives. Meanwhile, Stat takes a closer look at where everyone stands on developing coronavirus-related drugs and vaccines.
from Kaiser Health News https://ift.tt/2PYlxtZ
March 03, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Coronavirus Funding Bill Expands Medicare Telemedicine Options That May Last Far Longer Than Outbreak- Worry Mounts For Health Workers On The Front Line As Outbreak Spreads
- The Fatality Rate Is Key To Addressing An Epidemic. But It’s Also Hard To Get An Accurate Count In Middle Of Crisis.
- China’s Heavy-Handed Measures Seem To Be Working, But Can They Be Reproduced Outside A Communist Country?
- In Good Times Cost-Sharing Is Supposed To Encourage Smart Choices. During An Epidemic It Can Discourage Care.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment